Exchange: PNK Industry: Drug Manufacturers
0.76% $0.715
America/New_York / 28 mar 2024 @ 15:19
FUNDAMENTALS | |
---|---|
MarketCap: | 12.11 mill |
EPS: | -4.23 |
P/E: | -0.170 |
Earnings Date: | Apr 11, 2024 |
SharesOutstanding: | 16.93 mill |
Avg Daily Volume: | 0.296 mill |
RATING 2024-03-28 |
---|
B+ |
Neutral |
RATINGS | ||
---|---|---|
Rating CashFlow: | Buy | |
Return On Equity: | Sell | |
Return On Asset: | Neutral | |
DE: | Buy | |
P/E: | Sell | |
Price To Book: | Neutral |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
2/22 | 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | |
Revenue | ||||||
Gr.Profit | ||||||
Ebit | ||||||
Asset | ||||||
Debt |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE -0.170 | sector: PE -11.58 |
PE RATIO: COMPANY / INDUSTRY |
---|
0x |
Company: PE -0.170 | industry: PE -6.21 |
DISCOUNTED CASH FLOW VALUE |
---|
N/A |
N/A |
Expected Trading Range (DAY) |
---|
$ 0.647 - 0.783 ( +/- 9.51%) |
ATR Model: 14 days |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-02-16 | Siokas Grigorios | Buy | 60 000 | Common Stock, par value $.001 |
2023-12-22 | Aslidis Anastasios | Sell | 200 | Common Stock, $.001 par value |
2023-10-24 | Terzis Georgios | Buy | 51 485 | Common Stock, $.001 par value |
2023-10-12 | Siokas Grigorios | Buy | 6 712 | Common Stock, par value $0.001 per share |
2023-09-18 | Bhutawala Suhel | Sell | 0 | Common Stock, $.001 par value |
INSIDER POWER |
---|
86.45 |
Last 96 transactions |
Buy: 36 943 515 | Sell: 4 728 118 |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | $0.715 (0.76% ) |
Volume | 0.158 mill |
Avg. Vol. | 0.296 mill |
% of Avg. Vol | 53.41 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % |
---|
Cosmos Health Inc. operates as a vertically integrated pharmaceutical company. It offers a proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter medications, health care and baby products, medical devices, and other products through its distribution channels and an ecommerce marketplace. The company identifies, acquires, develops, and commercializes products that enhance patients' lives and outcomes, as well as has distribution centers in Greece and the United Kingdom; and operates a warehousing facility. It serves wholesale pharmaceutical distributors and independent retail pharmacies. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.